The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience

Formica, Vincenzo; Fossile, Emanuela; Pellegrino, R.; Fatale, M.; Mari, M.; Rabuffetti, M.; Benedetto, F. R.; Visconti, G.; Bollero, E; Roselli, Mario

doi:10.1007/s00520-008-0559-1

Cited by 7 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Indeed, in cancer survivals, physical symptoms and psychological distress altering and affecting their QoL, continuous care should be provided, being capable to improve the perceptions of their lives [12]. Current guidelines recommend the early integration of PC for patients with cancer [3,13], due to the demonstrated positive relationship between early integration of PC and improvements in QoL of both patients and caregivers, associated with a reduced access to pointless interventions and incongruent emergency department accesses [14][15][16][17].…”

Section: Integrated Palliative Care and Simultaneous Carementioning

confidence: 99%

Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care

Riondino

Ferroni

Monte

et al. 2020

Cancers

View full text Add to dashboard Cite

Simultaneous care represents the ideal integration between early supportive and palliative care in cancer patients under active antineoplastic treatment. Cancer patients require a composite clinical, social and psychological management that can be effective only if care continuity from hospital to home is guaranteed and if such a care takes place early in the course of the disease, combining standard oncology care and palliative care. In these settings, venous thromboembolism (VTE) represents a difficult medical challenge, for the requirement of acute treatments and for the strong impact on anticancer therapies that might be delayed or, even, totally discontinued. Moreover, cancer patients not only display high rates of VTE occurrence/recurrence but are also more prone to bleeding and this forces clinicians to optimize treatment strategies, balancing between hemorrhages and thrombus formation. VTE prevention is, therefore, regarded as a double-edged sword. Indeed, while on one hand the appropriate use of antithrombotic agents can reduce VTE occurrence, on the other it significantly increases the bleeding risk, especially in the frail patients who present with multiple co-morbidities and poly-therapy that can interact with anticoagulant drugs. For these reasons, thromboprophylaxis should start while active cancer treatment is ongoing, according to a simultaneous care model in a patient-centered perspective.

show abstract

Section: Integrated Palliative Care and Simultaneous Carementioning

confidence: 99%

Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care

Riondino

Ferroni

Monte

et al. 2020

Cancers

View full text Add to dashboard Cite

show abstract

“…The AEs generally appear during the days following treatment administration when patients are back home and thus are generally managed by phone calls where the patients call the oncology unit and less commonly the primary care provider. Unscheduled patient calls lack reliability and urgency and cause inappropriate use of healthcare provider time (Formica et al, 2009 ; Marcus, 2002 ). The ability to guarantee the continuity of care, especially in oncology, is a major challenge to optimise the organisation of the health system.…”

Section: Introductionmentioning

confidence: 99%

The Ambulatory Medical Assistance (AMA) programme during active‐phase treatment in patients with haematological malignancies: A cost‐effectiveness analysis

Michallet

Malartre

Vignaud

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

Context The need for patient navigator is growing, and there is a lack of cost evaluation, especially during survivorship. Objective The objective of this study is to evaluate the cost‐effectiveness of an Ambulatory Medical Assistance (AMA) programme in patients with haematological malignancies (HM). Design A cost‐effectiveness analysis of the AMA programme was performed compared to a simulated control arm. Setting An interventional, single‐arm and prospective study was conducted in a French reference haematology–oncology centre between 2016 and 2020. Participants Adult patients were enrolled with histologically documented malignant haematology, during their active therapy phase, and treated either by intravenous chemotherapy or oral therapy. Methods An extrapolation of the effectiveness was derived from a similar nurse monitoring programme (CAPRI study). Cost effectiveness of the programme was evaluated through adverse events of Grade 3 or 4 avoided in different populations. Results Included patient (n = 797) from the AMA programme were followed during 125 days (IQR: 0–181), and adverse events (Grade 3/4) were observed in 10.1% of patients versus 13.4% in the simulated control arm. The overall cost of AE avoided was estimated to €81,113, leading to an ICER of €864. Conclusion The AMA programme was shown to be cost‐effective compared to a simulated control arm with no intervention.

show abstract

“…Dans ces différents contextes, le lien avec le malade repose essentiellement sur l'appel « rentrant » (appel émis vers l'unité spécialisée). Malheureusement, ce type d'appel non programmé reste aléatoire, la demande souvent multiple et confuse et l'interlocuteur adéquat pas toujours présent ou disponible [4,8].…”

Section: Introductionunclassified

AMA (Assistance des malades ambulatoires) : une procédure de télémédecine appliquée à la prise en charge des lymphomes agressifs

et al. 2011

View full text Add to dashboard Cite

The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience

Abstract: The MCC system was well managed by both patients and caregivers. These results show that it has the potential to improve medical assistance by virtue of a constant access to medical advice and reduce unnecessary hospital admissions.

Cited by 7 publications

References 18 publications

Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care

Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care

The Ambulatory Medical Assistance (AMA) programme during active‐phase treatment in patients with haematological malignancies: A cost‐effectiveness analysis

AMA (Assistance des malades ambulatoires) : une procédure de télémédecine appliquée à la prise en charge des lymphomes agressifs

Contact Info

Product

Resources

About